Kiromic Biopharma, Inc. Research and Development Expense
Kiromic Biopharma, Inc. reported Research and Development Expense of $6.85 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-02-14
- Kiromic Biopharma, Inc. research and development expense for the quarter ending 2024-12-31 was -$4.53M, a 2078.60% decline year-over-year.
- Kiromic Biopharma, Inc. research and development expense for the quarter ending 2024-09-30 was $4.23M, a 57.94% increase year-over-year.
- Kiromic Biopharma, Inc. research and development expense for the quarter ending 2024-06-30 was $4.13M, a 110.22% increase year-over-year.
- Kiromic Biopharma, Inc. research and development expense for the quarter ending 2024-03-31 was $3.02M, a 45.64% increase year-over-year.
- Kiromic Biopharma, Inc. research and development expense for fiscal 2024 was $6.85M, a 1.35% decline from fiscal 2023.
- Kiromic Biopharma, Inc. research and development expense for fiscal 2023 was $6.95M, a 50.09% decline from fiscal 2022.
- Kiromic Biopharma, Inc. research and development expense for fiscal 2022 was $13.92M, a 22.45% increase from fiscal 2021.
- Kiromic Biopharma, Inc. research and development expense for fiscal 2021 was $11.37M, a 124.98% increase from fiscal 2020.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -$4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | -$303.00K derived: sum of 2 quarters · filed 2025-02-14 | $3.83M derived: sum of 3 quarters · filed 2025-02-14 | $6.85M 10-K · filed 2025-02-14 | ||||
| 2024-09-30 | $4.23M 10-Q · filed 2024-11-08 | $8.36M derived: sum of 2 quarters · filed 2024-11-08 | $11.38M 10-Q · filed 2024-11-08 | $11.61M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2024-06-30 | $4.13M 10-Q · filed 2024-08-09 | $7.16M 10-Q · filed 2024-08-09 | $7.39M derived: sum of 3 quarters · filed 2025-02-14 | $10.06M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2024-03-31 | $3.02M 10-Q · filed 2024-05-10 | $3.25M derived: sum of 2 quarters · filed 2025-02-14 | $5.93M derived: sum of 3 quarters · filed 2025-02-14 | $7.89M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-12-31 | $229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $2.91M derived: sum of 2 quarters · filed 2025-02-14 | $4.87M derived: sum of 3 quarters · filed 2025-02-14 | $6.95M 10-K · filed 2025-02-14 | $9.62M 10-K · filed 2024-03-19 | |||
| 2023-09-30 | $2.68M 10-Q · filed 2024-11-08 | $2.68M 10-Q · filed 2023-11-14 | $4.64M derived: sum of 2 quarters · filed 2024-11-08 | $6.72M 10-Q · filed 2024-11-08 | $6.72M 10-Q · filed 2023-11-14 | $10.05M derived: sum of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | $1.97M 10-Q · filed 2024-08-09 | $1.97M 10-Q · filed 2023-08-14 | $4.04M 10-Q · filed 2024-08-09 | $4.04M 10-Q · filed 2023-08-14 | $7.37M derived: sum of 3 quarters · filed 2024-08-09 | $11.16M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $2.08M 10-Q · filed 2024-05-10 | $5.40M derived: sum of 2 quarters · filed 2024-05-10 | $9.19M derived: sum of 3 quarters · filed 2024-05-10 | $13.07M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $7.11M derived: sum of 2 quarters · filed 2024-03-19 | $10.99M derived: sum of 3 quarters · filed 2024-03-19 | $13.92M 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | $3.78M 10-Q · filed 2023-11-14 | $7.66M derived: sum of 2 quarters · filed 2023-11-14 | $10.59M 10-Q · filed 2023-11-14 | $13.93M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $3.88M 10-Q · filed 2023-08-14 | $6.81M 10-Q · filed 2023-08-14 | $10.14M derived: sum of 3 quarters · filed 2023-08-14 | $13.63M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $2.93M 10-Q · filed 2023-05-15 | $6.26M derived: sum of 2 quarters · filed 2023-05-15 | $9.75M derived: sum of 3 quarters · filed 2023-05-15 | $12.41M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $6.82M derived: sum of 2 quarters · filed 2023-04-17 | $9.48M derived: sum of 3 quarters · filed 2023-04-17 | $11.37M 10-K · filed 2023-04-17 | ||||
| 2021-09-30 | $3.49M 10-Q · filed 2022-11-14 | $6.14M derived: sum of 2 quarters · filed 2022-11-14 | $8.03M 10-Q · filed 2022-11-14 | $9.56M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $2.66M 10-Q · filed 2022-08-12 | $4.54M 10-Q · filed 2022-08-12 | $6.07M derived: sum of 3 quarters · filed 2022-08-12 | $7.30M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $1.89M 10-Q · filed 2022-05-13 | $3.41M derived: sum of 2 quarters · filed 2022-05-13 | $4.64M derived: sum of 3 quarters · filed 2022-05-13 | $5.91M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $2.75M derived: sum of 2 quarters · filed 2022-04-08 | $4.02M derived: sum of 3 quarters · filed 2022-04-08 | $5.05M 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | $1.23M 10-Q · filed 2022-03-11 | $2.50M derived: sum of 2 quarters · filed 2022-03-11 | $3.53M 10-Q · filed 2022-03-11 | $4.13M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | $1.27M 10-Q · filed 2021-08-13 | $2.30M 10-Q · filed 2021-08-13 | $2.90M derived: sum of 3 quarters · filed 2021-08-13 | $3.17M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $1.03M 10-Q · filed 2021-05-14 | $1.63M derived: sum of 2 quarters · filed 2021-05-14 | $1.90M derived: sum of 3 quarters · filed 2021-05-14 | |||||
| 2019-12-31 | $600.20K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $872.30K derived: sum of 2 quarters · filed 2021-03-31 | $1.20M 10-K · filed 2021-03-31 | |||||
| 2019-09-30 | $272.10K 10-Q · filed 2020-11-30 | $601.50K 10-Q · filed 2020-11-30 |